Trescal has acquired RS Calibration, an A2LA accredited calibration, qualification and validation laboratory dedicated to the life science industry.
Founded in 1995 and based in Pleasanton (Northeast of San Francisco), RS Calibration employs 41 people and provides in house or on site calibration and validation services specifically for the Pharmaceutical, Medical Device, and Biotech production environments. The company has high calibration expertise in the FDA and cGMP environments and its sales reached $5.5 million in 2017.
The CEO and founder, Ralph Sabiel, will remain in his current position to pursue the development of the company within Trescal Group.
Guillaume Caroit, Trescal Deputy CEO, said: “This acquisition is very important for the development of Trescal in the United States. It will strengthen our coverage in California and reinforces our ability to serve the life science industry. ”
This acquisition is the first to be completed subsequent to OMERS, the defined benefit pension plan for municipal employees in the Province of Ontario, Canada, becoming Trescal’s main shareholder.